I-Mab Biopharma
IMAB
#9469
Rank
C$78.79 M
Marketcap
$0.97
Share price
-6.87%
Change (1 day)
-61.13%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$21.04 Million

According to I-Mab Biopharma's latest financial reports the company's total liabilities are C$21.04 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$23.68 M-28.63%
2022-12-31C$33.18 M1.54%
2021-12-31C$32.68 M54.57%
2020-12-31C$21.14 M-79.02%
2019-12-31C$0.10 B5.09%
2018-12-31C$95.91 M144.52%
2017-12-31C$39.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$17.28 M-17.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.18 B 5,540.68%๐Ÿ‡บ๐Ÿ‡ธ USA